Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Preclinical safety of tetrahydrocurcumin loaded lipidic nanoparticles incorporated into tacrolimus ointment: In vitro and in vivo evaluation.

Authors:
Komal Saini Caamin Arora Megha Saini Saurabh Sharma Deepak Chitkara Vandita Kakkar

Food Chem Toxicol 2022 Sep 28;167:113260. Epub 2022 Jun 28.

Department of Pharmaceutics, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India. Electronic address:

Preclinical safety and proof of concept studies for a topical ointment comprising of concentrated tetrahydrocurcumin loaded lipidic nanoparticles (THC-LNs) and tacrolimus ointment (TTO) is proposed in the present investigation. The skin irritation potential and acute dermal toxicity were performed in rats in compliance with the Organization for Economic Cooperation and Development (OECD) guidelines (402, 404 and 410) while the cytotoxic potential was performed in HaCaT cells. Finally, in vivo evaluation was performed in Imiquimod mice model of psoriasis. In primary skin irritation assessment, TTO formulation, marketed formulation (Tacroz® Forte), THC-LNs, and blank LNs were topically applied on intact skin sites in rats while another group served as a negative control group for 72 h. TTO did not induce any adverse reactions. Repeated 28 days dermal toxicity followed by biochemical and histopathological assessment showed negligible alternations and skin lesions. THC-LNs revealed negligible cytotoxic potential in HaCaT cells. TTO showed significantly high anti-psoriatic activity in comparison to marketed ointment. This was also confirmed via histopathological evaluation. Based on these findings, it can be ascertained that TTO showed minimal toxicity and has ample potential for further clinical analysis. The above studies affirm the potential of TTO as an alternative for psoriasis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fct.2022.113260DOI Listing
September 2022

Publication Analysis

Top Keywords

lipidic nanoparticles
8
vivo evaluation
8
cytotoxic potential
8
skin irritation
8
hacat cells
8
tetrahydrocurcumin loaded
8
loaded lipidic
8
dermal toxicity
8
tacrolimus ointment
8
preclinical safety
8
tto
6
potential
5
rats group
4
alternative psoriasis
4
sites rats
4
skin sites
4
intact skin
4
group served
4
control group
4
served negative
4

Keyword Occurance

Similar Publications

Nose to brain delivery of melatonin lipidic nanocapsules as a promising post-ischemic neuroprotective therapeutic modality.

Authors:
Eman A Bseiso Sarah A AbdEl-Aal Maha Nasr Omaima A Sammour Nabaweya A Abd El Gawad

Drug Deliv 2022 Dec;29(1):2469-2480

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, October 6 University, Giza Governorate, Egypt.

Ischemic stroke accounts for about 87% of all strokes, causing long-term disability in adults, and is the second leading cause of death worldwide. In search of new therapeutic modalities, the use of neuroprotective agents loaded in nanocarriers to be delivered by noninvasive means (i.e. Read More

View Article and Full-Text PDF
December 2022
Similar Publications

Characterization of a Mesoporous Silica Nanoparticle Formulation Loaded with Mitomycin C Lipidic Prodrug (MLP) and In Vitro Comparison with a Clinical-Stage Liposomal Formulation of MLP.

Authors:
Miguel Manzano Alberto Gabizón María Vallet-Regí

Pharmaceutics 2022 Jul 17;14(7). Epub 2022 Jul 17.

Chemistry in Pharmaceutical Sciences, School of Pharmacy, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, Plaza de Ramón y Cajal s/n, 28040 Madrid, Spain.

Nanomedicines have revolutionized the treatment of certain types of cancer, as is the case of doxil, liposomal formulation with doxorubicin encapsulated, in the treatment of certain types of ovarian cancer, AIDS-related Kaposi sarcoma, and multiple myeloma. These nanomedicines can improve the performance of conventional chemotherapeutic treatments, with fewer side effects and better efficiency against cancer. Although liposomes have been used in some formulations, different nanocarriers with better features in terms of stability and adsorption capabilities are being explored. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease.

Authors:
Julen Rodríguez-Castejón Itziar Gómez-Aguado Marina Beraza-Millor María Ángeles Solinís Ana Del Pozo-Rodríguez Alicia Rodríguez-Gascón

Nanomaterials (Basel) 2022 Jul 8;12(14). Epub 2022 Jul 8.

Pharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigación Lascaray Ikergunea, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.

Gene supplementation therapy with plasmid DNA (pDNA) represents one of the most promising strategies for the treatment of monogenic diseases such as Fabry disease (FD). In the present work, we developed a solid lipid nanoparticles (SLN)-based non-viral vector with a size below 100 nm, and decorated with galactomannan (GM) to target the liver as an α-Galactosidase A (α-Gal A) production factory. After the physicochemical characterization of the GM-SLN vector, cellular uptake, transfection efficacy and capacity to increase α-Gal A activity were evaluated in vitro in a liver cell line (Hep G2) and in vivo in an animal model of FD. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Luminescent Gold Nanoclusters Interacting with Synthetic and Biological Vesicles.

Authors:
Regina M Chiechio Solène Ducarre Grégory Moulin Aurélien Dupont Célia Marets Pascale Even-Hernandez Franck Artzner Paolo Musumeci Giorgia Franzò Célia Ravel Maria José LoFaro Valérie Marchi

J Phys Chem Lett 2022 Aug 24;13(30):6935-6943. Epub 2022 Jul 24.

Université Rennes 1, CNRS UMR 6226, Institut des Sciences Chimiques de Rennes, Avenue du général Leclerc, 35042 Rennes Cedex, France.

According to their high electron density and ultrasmall size, gold nanoclusters (AuNCs) have unique luminescence and photoelectrochemical properties that make them very attractive for various biomedical fields. These applications require a clear understanding of their interaction with biological membranes. Here we demonstrate the ability of the AuNCs as markers for lipidic bilayer structures such as synthetic liposomes and biological extracellular vesicles (EVs). Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Production of Q10+B2 nanostructured lipid carriers and optimization of their entrapment capacities.

Authors:
P Trucillo D Sofia L Cortese M Urciuolo

Colloids Surf B Biointerfaces 2022 Jun 22;217:112653. Epub 2022 Jun 22.

Consiglio Nazionale delle Ricerche, Scienze e Tecnologie per l'Energia e la Mobilità Sostenibili (CNR-STEMS), Piazzale Tecchio, 80, 80125 Napoli, Italy.

Lipidic carriers are efficient vehicles preserving drugs during cell administration. Several production processes of lipidic nanoparticles were developed to reduce mean size at nanometric level, enhancing homogeneity and process replicability. However, lipidic aggregation has always been considered a huge drawback in terms of high polidispersity and instability. Read More

View Article and Full-Text PDF
June 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap